Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1995 Oct-Dec;1(4):107–114. doi: 10.3201/eid0104.950401

The ascension of wildlife rabies: a cause for public health concern or intervention?

C E Rupprecht 1, J S Smith 1, M Fekadu 1, J E Childs 1
PMCID: PMC2626887  PMID: 8903179

Abstract

The epidemiology of rabies in the United States has changed substantially during the last half century, as the source of the disease has changed from domesticated animals to wildlife, principally raccoons, skunks, foxes, and bats. Moreover, the changes observed among affected wildlife populations have not occurred without human influence. Rather, human attraction to the recreational and economic resources provided by wildlife has contributed to the reemergence of rabies as a major zoonosis. Although human deaths caused by rabies have declined recently to an average of one or two per year, the estimated costs associated with the decrease in deaths amount to hundreds of millions of dollars annually. In future efforts to control rabies harbored by free-ranging animal reservoirs, public health professionals will have to apply imaginative, safe, and cost-effective solutions to this age-old malady in addition to using traditional measures.

Full Text

The Full Text of this article is available as a PDF (68.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson L. J., Nicholson K. G., Tauxe R. V., Winkler W. G. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann Intern Med. 1984 May;100(5):728–735. doi: 10.7326/0003-4819-100-5-728. [DOI] [PubMed] [Google Scholar]
  2. Baer G. M. Oral rabies vaccination: an overview. Rev Infect Dis. 1988 Nov-Dec;10 (Suppl 4):S644–S648. doi: 10.1093/clinids/10.supplement_4.s644. [DOI] [PubMed] [Google Scholar]
  3. Baer G. M. Rabies--an historical perspective. Infect Agents Dis. 1994 Aug;3(4):168–180. [PubMed] [Google Scholar]
  4. Carey A. B., Giles R. H., McLean R. G. The landscape epidemiology of rabies in Virginia. Am J Trop Med Hyg. 1978 May;27(3):573–580. doi: 10.4269/ajtmh.1978.27.573. [DOI] [PubMed] [Google Scholar]
  5. Centers for Disease Control (CDC) Human rabies--Texas, Arkansas, and Georgia, 1991. MMWR Morb Mortal Wkly Rep. 1991 Nov 8;40(44):765–769. [PubMed] [Google Scholar]
  6. Centers for Disease Control and Prevention (CDC) Human rabies--Alabama, Tennessee, and Texas, 1994. MMWR Morb Mortal Wkly Rep. 1995 Apr 14;44(14):269–272. [PubMed] [Google Scholar]
  7. Centers for Disease Control and Prevention (CDC) Human rabies--Washington, 1995. MMWR Morb Mortal Wkly Rep. 1995 Sep 1;44(34):625–627. [PubMed] [Google Scholar]
  8. Centers for Disease Control and Prevention (CDC) Raccoon rabies epizootic--United States, 1993. MMWR Morb Mortal Wkly Rep. 1994 Apr 22;43(15):269–273. [PubMed] [Google Scholar]
  9. Centers for Disease Control and Prevention (CDC) Translocation of coyote rabies--Florida, 1994. MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):580-1, 587. [PubMed] [Google Scholar]
  10. Fishbein D. B., Arcangeli S. Rabies prevention in primary care. A four-step approach. Postgrad Med. 1987 Sep 1;82(3):83-90, 93-5. doi: 10.1080/00325481.1987.11699951. [DOI] [PubMed] [Google Scholar]
  11. Fishbein D. B., Robinson L. E. Rabies. N Engl J Med. 1993 Nov 25;329(22):1632–1638. doi: 10.1056/NEJM199311253292208. [DOI] [PubMed] [Google Scholar]
  12. Foggin C. M. Mokola virus infection in cats and a dog in Zimbabwe. Vet Rec. 1983 Jul 30;113(5):115–115. doi: 10.1136/vr.113.5.115. [DOI] [PubMed] [Google Scholar]
  13. Hanlon C. A., Buchanan J. R., Nelson E., Niu H. S., Diehl D., Rupprecht C. E. A vaccinia-vectored rabies vaccine field trial: ante- and post-mortem biomarkers. Rev Sci Tech. 1993 Mar;12(1):99–107. doi: 10.20506/rst.12.1.669. [DOI] [PubMed] [Google Scholar]
  14. Hanlon C. L., Hayes D. E., Hamir A. N., Snyder D. E., Jenkins S., Hable C. P., Rupprecht C. E. Proposed field evaluation of a rabies recombinant vaccine for raccoons (Procyon lotor): site selection, target species characteristics, and placebo baiting trials. J Wildl Dis. 1989 Oct;25(4):555–567. doi: 10.7589/0090-3558-25.4.555. [DOI] [PubMed] [Google Scholar]
  15. Held J. R., Tierkel E. S., Steele J. H. Rabies in man and animals in the United States, 1946-65. Public Health Rep. 1967 Nov;82(11):1009–1018. [PMC free article] [PubMed] [Google Scholar]
  16. Helmick C. G. The epidemiology of human rabies postexposure prophylaxis, 1980-1981. JAMA. 1983 Oct 21;250(15):1990–1996. [PubMed] [Google Scholar]
  17. King A. A., Meredith C. D., Thomson G. R. The biology of southern African lyssavirus variants. Curr Top Microbiol Immunol. 1994;187:267–295. doi: 10.1007/978-3-642-78490-3_15. [DOI] [PubMed] [Google Scholar]
  18. Krebs J. W., Strine T. W., Smith J. S., Rupprecht C. E., Childs J. E. Rabies surveillance in the United States during 1993. J Am Vet Med Assoc. 1994 Dec 15;205(12):1695–1709. [PubMed] [Google Scholar]
  19. Rupprecht C. E., Charlton K. M., Artois M., Casey G. A., Webster W. A., Campbell J. B., Lawson K. F., Schneider L. G. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis. 1990 Jan;26(1):99–102. doi: 10.7589/0090-3558-26.1.99. [DOI] [PubMed] [Google Scholar]
  20. Rupprecht C. E., Dietzschold B., Cox J. H., Schneider L. G. Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine. J Wildl Dis. 1989 Oct;25(4):548–554. doi: 10.7589/0090-3558-25.4.548. [DOI] [PubMed] [Google Scholar]
  21. Rupprecht C. E., Hamir A. N., Johnston D. H., Koprowski H. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev Infect Dis. 1988 Nov-Dec;10 (Suppl 4):S803–S809. doi: 10.1093/clinids/10.supplement_4.s803. [DOI] [PubMed] [Google Scholar]
  22. Rupprecht C. E., Hanlon C. A., Niezgoda M., Buchanan J. R., Diehl D., Koprowski H. Recombinant rabies vaccines: efficacy assessment in free-ranging animals. Onderstepoort J Vet Res. 1993 Dec;60(4):463–468. [PubMed] [Google Scholar]
  23. Sasaki D. M., Middleton C. R., Sawa T. R., Christensen C. C., Kobayashi G. Y. Rabid bat diagnosed in Hawaii. Hawaii Med J. 1992 Jul;51(7):181–185. [PubMed] [Google Scholar]
  24. Stehr-Green J. K., Schantz P. M. The impact of zoonotic diseases transmitted by pets on human health and the economy. Vet Clin North Am Small Anim Pract. 1987 Jan;17(1):1–15. doi: 10.1016/s0195-5616(87)50601-5. [DOI] [PubMed] [Google Scholar]
  25. Swanepoel R., Barnard B. J., Meredith C. D., Bishop G. C., Brückner G. K., Foggin C. M., Hübschle O. J. Rabies in southern Africa. Onderstepoort J Vet Res. 1993 Dec;60(4):325–346. [PubMed] [Google Scholar]
  26. Uhaa I. J., Dato V. M., Sorhage F. E., Beckley J. W., Roscoe D. E., Gorsky R. D., Fishbein D. B. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons. J Am Vet Med Assoc. 1992 Dec 15;201(12):1873–1882. [PubMed] [Google Scholar]
  27. Wiktor T. J., Macfarlan R. I., Reagan K. J., Dietzschold B., Curtis P. J., Wunner W. H., Kieny M. P., Lathe R., Lecocq J. P., Mackett M. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A. 1984 Nov;81(22):7194–7198. doi: 10.1073/pnas.81.22.7194. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES